The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology
The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology
Suzhou, Jiangsu, China6 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of A Venetoclax-based, Anthracycline-free Regimen in Newly Diagnosed CBFβ::MYH11(+) AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Phase 2 | 2026-09-09 | NCT06429098 | |
| VA vs DA for Newly Diagnosed Hig-risk AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 2 / Phase 3 | 2026-09-02 | NCT05939180 | |
| Efficacy, Safety, and Pharmacokinetics of ThisCART19A Combined With Olverembatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. | Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia | Recruiting | Early phase 1 | 2026-06-17 | NCT07074496 | |
| Peripheral Blood KIT-D816V Mutation in Adult Systemic Mastocytosis | Mast Cell Activation Disorders, Mastocytosis, Systemic, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, immune system disorder, mastocytosis, neoplasm | Recruiting | Not stated | 2026-05-01 | NCT07562542 | |
| Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Phase 3 | 2024-10-03 | NCT05177731 | |
| AZA + Venetoclax as Maintenance Therapy in Younger Adults With AML in First Remission | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 2 / Phase 3 | 2022-08-19 | NCT05404906 |